Aska Pharmaceutical Co
Aska Pharmaceutical Co., Ltd., commonly referred to as Aska Pharma, is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in Japan. Established in 1941, the company has made significant strides in developing innovative healthcare solutions, focusing on prescription pharmaceuticals and over-the-counter products.
With a strong operational presence in various regions, Aska Pharma is dedicated to enhancing patient care through its unique offerings, which include high-quality generic medications and specialty pharmaceuticals. The company is recognised for its commitment to research and development, leading to notable achievements in therapeutic areas such as cardiovascular health and oncology. Aska Pharmaceutical Co. continues to solidify its market position by prioritising quality and efficacy, making it a trusted name in the global pharmaceutical landscape.
-18 vs industry average
Aska Pharmaceutical Co’s score of 21 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Aska Pharmaceutical Co?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2025
Reported emissions
Scope 3 accounts for ••• of total emissions.
Aska Pharmaceutical Co's reported carbon emissions
Aska Pharmaceutical Co., based in Japan and operating in the Pharmaceutical Preparation Manufacturing industry, reported approximately 10.78 million kg CO2e in 2022. This figure encompasses Scope 1 and Scope 2 emissions. For 2021, the company's Scope 1 and Scope 2 emissions were approximately 12.25 million kg CO2e. In 2020, Aska Pharmaceutical Co. reported Scope 1 and Scope 2 emissions of approximately 13.22 million kg CO2e.
The company has not disclosed Scope 3 emissions for these reporting years. There is no information available on specific reduction targets or achievements by Aska Pharmaceutical Co. directly. The data is not cascaded from a parent organisation.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Aska Pharmaceutical Co’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Aska Pharmaceutical Co yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project